Unibest 优贝德
← Back to patent-cliff list

盐酸替拉凡星

Tier C — Watch / trade

Telavancin Hydrochloride

Theravance Biopharma Inc
Originator
2009
First approval
-
Expiry (public)
$0.01B ▲
Peak sales
化学药
Type

TargetsPeptidoglycan

BrandArbelic、Vibativ

Indications (approved)呼吸机相关性肺炎、细菌性肺炎、医院获得性肺炎、医疗保健相关性肺炎、复杂皮肤和皮肤结构感染

Regional status

US
批准上市
2009-09-11
EU
撤市
China
批准上市
2025-02-11
Japan
-

Synthetic routes & intermediates3 routes

Originator routes × 1Optimised (non-patent) × 2Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 5 · Total yield 3.05 g
Synthetic routes & intermediates Route 1
CodeCAS No.Intermediate
TELA-0015196-28-82-(decylamino)ethan-1-ol
TELA-002239088-19-8(9H-fluoren-9-yl)methyl decyl(2-hydroxyethyl)carbamate
TELA-003239088-22-3(9H-fluoren-9-yl)methyl decyl(2-oxoethyl)carbamate
TELA-0041404-90-6Vancomycin
TELA-005281229-92-3Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-
TELA-006281226-43-5Vancomycin, N3''-[2-(decylamino)ethyl]-
TELA-0071066-51-9(aminomethyl)phosphonic acid
OptimisedRoute 2Steps 3 · Total yield /
Synthetic routes & intermediates Route 2
CodeCAS No.Intermediate
TELA-003239088-22-3(9H-fluoren-9-yl)methyl decyl(2-oxoethyl)carbamate
TELA-0041404-90-6Vancomycin
TELA-0071066-51-9(aminomethyl)phosphonic acid
TELA-0081426831-63-1Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethylidene]-
TELA-0091426831-64-2Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethylidene]-29-[[(phosphonomethyl)amino]methyl]-
OptimisedRoute 3Steps 4 · Total yield /
Synthetic routes & intermediates Route 3
CodeCAS No.Intermediate
TELA-003239088-22-3(9H-fluoren-9-yl)methyl decyl(2-oxoethyl)carbamate
TELA-0041404-90-6Vancomycin
TELA-005281229-92-3Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-
TELA-0071066-51-9(aminomethyl)phosphonic acid
TELA-0081426831-63-1Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethylidene]-
TELA-0101426832-37-2Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-29-[[(phosphonomethyl)amino]methyl]-

Frequently asked questions

What are the approved indications of Telavancin Hydrochloride?

Approved indications include: 呼吸机相关性肺炎, 细菌性肺炎, 医院获得性肺炎, 医疗保健相关性肺炎, 复杂皮肤和皮肤结构感染.

When does the Telavancin Hydrochloride patent expire?

No public expiry year is available for Telavancin Hydrochloride yet; this page updates once verified.

How many synthesis routes are recorded for Telavancin Hydrochloride?

3 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Telavancin Hydrochloride intermediates?

All intermediates in Telavancin Hydrochloride routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Telavancin Hydrochloride intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-24